Lynn Seely - 09 Feb 2024 Form 4 Insider Report for Lyell Immunopharma, Inc. (LYEL)

Signature
/s/ Charles Newton, as Attorney-in-Fact
Issuer symbol
LYEL
Transactions as of
09 Feb 2024
Net transactions value
$0
Form type
4
Filing time
13 Feb 2024, 20:17:30 UTC
Previous filing
20 Nov 2023
Next filing
14 Jun 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LYEL Common Stock Award $0 +200,000 $0.000000 200,000 09 Feb 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction involved the Reporting Person's receipt of a grant of performance-based restricted stock units, subject to vesting upon the achievement of specified performance criteria. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.